Study of EQ001 (Itolizumab) in Systemic Lupus Erythematosus With or Without Active Proliferative Nephritis
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
25 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Post Graduate Institute of Medical Education and Research (pgimer)
Chandigarh, India
- Medanta - the Medicity Hospital
Gurugramam, India
- Max Super Specialty Hospital
New Delhi, India
- Jawaharlal Nehru Institute of Postgraduate Medical Education and Research (jipmer)
Puducherry, India
- Sp Zoz Centralny Szpital Kliniczny Uniwersytetu Medycznego W Lodzi, Klinika Nefrologii, Hipertensjologii
Lodz, Poland
- Miedzyleski Szpital Specjalistyczny W Warszawie, Oddzial Nefrologiczny I Stacja Dializ
Warsaw, Poland
- Akdhc Medical Research Services, Llc
Sun City, Arizona, United States
- California Institute of Renal Research
Chula Vista, California, United States
- University of California San Diego Perlman Ambulatory Clinic
La Jolla, California, United States
- Clinical Research of West Florida - Clearwater
Clearwater, Florida, United States
- Centre for Rheumatology, Immunology and Arthritis
Fort Lauderdale, Florida, United States
- University of Florida, Division of Rheumatology
Gainesville, Florida, United States
- Clinical Site Partners Leesburg, Llc
Leesburg, Florida, United States
- Hope Clinical Trials
Miami, Florida, United States
- Southcoast Research Center Inc
Miami, Florida, United States
- Omega Research Maitland, Llc
Orlando, Florida, United States
- Clinical Research of West Florida - Tampa
Tampa, Florida, United States
- University of South Florida
Tampa, Florida, United States
- Georgia Nephrology
Lawrenceville, Georgia, United States
- Northwell Health / Division of Rheumatology
Great Neck, New York, United States
- Columbia University Medical Center, Div of Nephrology
New York, New York, United States
- Albert Einstein College of Medicine, Montefiore Medical Center
The Bronx, New York, United States
- Northeast Clinical Research Center, Llc
Bethlehem, Pennsylvania, United States
- Dallas Renal Group
Dallas, Texas, United States
- Prolato Clinical Research Center (pcrc)
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Oct 2019
- Primary completion
- 16 Nov 2023
- Completion
- 18 Jan 2024
- Last update posted
- 4 Jun 2026
- Registered enrollment
- 52
- Registry id
- NCT04128579
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.